UBS Group AG - YUMANITY THERAPEUTICS INC ownership

YUMANITY THERAPEUTICS INC's ticker is YMTX and the CUSIP is 98872L102. A total of 30 filers reported holding YUMANITY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of YUMANITY THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$21,000
+950.0%
11,479
+1455.4%
0.00%
Q4 2021$2,000
-83.3%
738
-36.5%
0.00%
Q3 2021$12,000
-53.8%
1,162
-48.5%
0.00%
Q2 2021$26,000
+420.0%
2,258
+678.6%
0.00%
Q1 2021$5,0002900.00%
Other shareholders
YUMANITY THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 108,847$1,850,0001.42%
SPHERA FUNDS MANAGEMENT LTD. 130,434$2,217,0000.20%
HARBOURVEST PARTNERS LLC 22,030$375,0000.15%
Redmile Group, LLC 611,003$10,387,0000.13%
Ikarian Capital, LLC 132,514$2,253,0000.10%
Artal Group S.A. 217,391$3,696,0000.08%
Maven Securities LTD 43,478$739,0000.07%
Bain Capital Public Equity Management II, LLC 31,331$533,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 14,498$246,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11,000$187,0000.00%
View complete list of YUMANITY THERAPEUTICS INC shareholders